Clinical trial
Efficacy of Topical Cyclosporin for Ocular Rosacea
NCT00348335 · Ophthalmic Consultants of Long Island, Other · Completed
Key facts
| NCT number | NCT00348335 |
|---|---|
| Title | Efficacy of Topical Cyclosporin for Ocular Rosacea |
| Official title | Efficacy of Topical Cyclosporin 0.05% for the Treatment of Ocular Rosacea |
| Lead sponsor | Ophthalmic Consultants of Long Island, Other |
| Collaborators | Allergan Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rosacea |
| Intervention type | Drug |
| Interventions | Cyclosporine 0.05%, Ocular lubricant |
| Enrollment | 35 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Jul 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: